Univariate analyses of the two groups revealed that long OS or SPP were associated with prognostic factors such as c-reactive protein (CRP) and advanced lung cancer inflammation index (ALI), indicating better clinical characteristics of patients continuing immunotherapy[18]. Here, CRP is linked to lung carcinoma.